CDD is excited to announce the opening of its BioHarmony Beta Program. BioHarmony is a centralized drug data store, providing semantic data on preclinical, clinical, and postapproval developments. Check out the debut of the BioHarmony Drug Data Store from our latest webinar below.
We are now accepting a limited number of enthusiastic applicants into our Beta Program. Beta testers will receive access to our entire BioHarmony Drug Data Store at a substantial discount while providing feedback to guide our product roadmap. If you are interested, please fill out the form below or contact us directly at support@biometadata.com.
Other posts you might be interested in
View All Posts
CDD Vault Updates
14 min
June 13, 2025
June Q2 2025 - Product Update Webinar: AI+ and Curves
Read More
CDD Blog
31 min
June 12, 2025
Top Scientific Data Platforms for AI-Driven Drug Discovery: What to Look For
Read More
CDD Blog
20 min
June 6, 2025
Synthetic Lethality in Precision Oncology: Integrating AI-Driven Discovery with Data Management Platforms
Read More